HopeStage
Back to all studies
CompletedNCT07181122

Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Observational studyAges 18+TürkiyeDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Ankara and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 22, 2025
Recruitment status
Completed
Enrollment listed in the registry
230
Sponsor
Ankara Etlik City Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Drug
Locations
Türkiye
Age range
Over 18 Years
Official registry ID
NCT07181122
Official title
Show the full official title

Prospective Observational Evaluation of Quality of Life, Functional Status, and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer Undergoing Androgen Receptor Pathway Inhibitor Therapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ankara, Türkiye · Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ankara Etlik City Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Androgen Receptor Pathway Inhibitors (ARPIs).

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies